Literature DB >> 8071260

Treatment strategies in the polydipsia-hyponatremia syndrome.

W V Vieweg1.   

Abstract

The clinician must first identify the patient at risk of developing water intoxication and its complications including seizures, coma, and death. In the polydipsic patient, behavioral approaches correcting or limiting polydipsia may prevent progression to dilutional hyponatremia. Drugs that oppose the central release or renal action of antidiuretic hormone will usually normalize morning serum sodium concentration in patients with the polydipsia-hyponatremia syndrome. The clinician can monitor such patients by observing diurnal changes in body weight. Specific interventions derive from specific weight changes. For the symptomatic patient suffering from water intoxication, intravenous administration of saline raising the serum sodium concentration to the 120-mmol/L range, followed by fluid restriction to further correct hyponatremia, will almost always successfully correct hyponatremia and protect against central pontine myelinolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071260

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  A lethal complication of psychogenic polydipsia: cerebral edema and herniation.

Authors:  J J Ligtenberg; A N Wymenga; J E Tulleken; T S van der Werf; J G Zijlstra
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 2.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

3.  Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.

Authors:  W V Vieweg; R A Leadbetter
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

4.  Psychogenic polydipsia: the result, or cause of, deteriorating psychotic symptoms? A case report of the consequences of water intoxication.

Authors:  Melissa Gill; MacDara McCauley
Journal:  Case Rep Psychiatry       Date:  2015-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.